| |OCTOBER 20259FUJIFILM INDIA LAUNCHES DIGITAL X-RAY FACILITY IN DHOLERAINDIA, MEXICO DISCUSS PHARMA INDUSTRY EXPANSION OPPORTUNITIESIndia and Mexico have opened up strategic talks that focus on expanding the Indian pharmaceutical industry's opportunities. The communication is designed to provide better access to cheaper drugs in Mexico, to promote the mutual recognition of the Indian Pharmacopoeia (IP) and to support investments in clinical research.Records of the discussions are that the Consulate of Mexico in Mumbai organized it in collaboration with the Pharmaceuticals Export Promotion Council of India (Pharmexcil). The talks focused on trade expansion and regulatory harmonization. India is thanked for the offer of better access to the market, which could facilitate overcoming of regulatory barriers and also enabling more sectoral collaboration.Pharmexcil Director Murali Krishna mentioned that Mexico represents the Latin American and the Caribbean's largest pharmaceutical market for which the value in 2024 was $17.2 billion, with imports worth $6.5 billion. India's pharma exports to Mexico were $320 million in 2023.New Delhi pharma companies have been invited to invest in domestic production under the "Made in Mexico" initiative. Sergio Silva from Mexico's Ministry of Economy gave an overview of the country's industrial policies, incentives for R&D, and a 2030 vision focusing on reaching $2 billion annual investment in clinical research and a 15% increase in pharma manufacturing.They also spoke about the simplification of regulations, the opportunities that exist in the field of biosimilars and generics, and the joint efforts to obtain health self-sufficiency through the production of vaccines and generics for critical diseases. POFUJIFILM India, a worldwide leader in healthcare technology, has opened an advanced digital radiology X-Ray facility at the Community Health Centre (CHC) in Dholera.This initiative, part of the company's CSR initiative, is intended to address critical healthcare gaps in one of India's most rapidly expanding industrial areas.As the inaugural central DR X-ray hub in the region, the facility will facilitate diagnostic support for the developing workforce in the city, as well as villages nearby.Apart from DR X-ray services, which will improve the speed and accuracy of diagnosis, the Fujifilm Medical Centre at CHC will conduct sputum collection for early tuberculosis screening, and, also run health camps to promote preventive healthcare on a regular basis.Speaking on the development, Koji Wada, Managing Director, FUJIFILM India, said, "At FUJIFILM India, our purpose goes beyond technology, we aim to create an impact that strengthens communities and supports national priorities...ensuring that workers, residents, and families have reliable support as the city grows into a global manufacturing hub."This CSR initiative affirms FUJIFILM India's aim to support healthcare access, along with industrial and smart city development. It offers a purpose of matching healthcare needs with economic progress, reaffirming the company's goal of making good preventive and diagnostic service available where it is most needed.The launch marks FUJIFILM India's intention of building healthcare infrastructure for Dholera, leading to increase access to reliable medical care in line with rapid industrial development in the city. PO
< Page 8 | Page 10 >